HCPCS Level IIdrugActive
J1323
Inj, elranatamab-bcmm, 1 mg
BETOS: O1D
Effective: 2024-04-01
Description
Injection, elranatamab-bcmm, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Elrexfio
Manufacturer
Pfizer Inc
HCPCS Dosage
1 MG
Billing Units
44.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.